Skip to main content
ApexBio logo

ApexBio — Investor Relations & Filings

Ticker · 1733 ISIN · TW0001733004 TW Manufacturing
Open in API
Filings indexed 1,559 across all filing types
Latest filing 2026-05-22 Notice of Dividend Amou…
Country TW Taiwan
Listing TW 1733

About ApexBio

www.apexbio.com.tw

ApexBio is a developer and manufacturer of in-vitro diagnostic (IVD) solutions, specializing in biosensor technology. The company provides a comprehensive range of products, including self-monitoring blood glucose systems, multi-functional home health management devices, and point-of-care testing (POCT) equipment. Its core operations encompass the research, development, production, and global distribution of diagnostic tools designed for both home care and professional clinical environments. Recognized for its innovation in home-care blood glucose monitoring, the company leverages its technological foundation to offer integrated solutions for chronic disease management and professional clinical trials. ApexBio focuses on enhancing healthcare accessibility through reliable diagnostic innovation and a full range of IVD services.

Recent filings

Filing Released Lang Actions
公告本公司決議除息基準日
Notice of Dividend Amount Classification · 88% confidence The document is a formal announcement by the company regarding its dividend distribution details: record date, ex-dividend date, amount per share (NT$1.3), total dividend amount, payment date, and related key dates. This matches the definition of a Notice of Dividend Amount (Code: DIV).
2026-05-22 Chinese
公告本公司115年股東常會重要決議事項
Declaration of Voting Results & Voting Rights Announcements Classification · 89% confidence The document is an announcement by a listed company of the resolutions passed at its Annual General Meeting (股東常會). It lists the meeting date and the key approved items (profit distribution, business report and financial statements, etc.), which is exactly a declaration of shareholder vote results. Therefore, it fits the Declaration of Voting Results & Voting Rights Announcements category (DVA).
2026-05-22 Chinese
115年第1季財務報告書 — 202601_1733_AIA.pdf
Interim / Quarterly Report Classification · 94% confidence The document contains the actual consolidated financial statements (balance sheet, income statement, changes in equity, cash flows) for the three months ended March 31, 2026 and 2025, accompanied by an independent auditor’s review report under IAS 34 (“Interim Financial Reporting”). It is a full interim/quarterly report with substantive financial data, not merely an announcement or certification. Therefore it meets the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-21 English
115年05月僑外投資持股
Regulatory Filings Classification · 75% confidence The document is a routine disclosure in Chinese of overseas and Mainland shareholding statistics for securities code 1733, prepared for filing with the public information observatory. It does not present voting results, financial statements, a report publication notice, nor any executive or board changes. It is a standard regulatory data submission that does not fit specialized categories, so it falls under the general Regulatory Filings (RNS) fallback category.
2026-05-13 Chinese
115年第1季海外子公司投資
Interim / Quarterly Report Classification · 85% confidence The document is a substantive table disclosing Q1 investment under the equity method for a listed company (“115年1季申報作業”), including numeric balances and recognized investment profit. It contains detailed interim financial data rather than merely announcing or linking to a report. This fits the definition of an Interim / Quarterly Report. Q1 2026
2026-05-12 Chinese
115年第1季大陸投資
Regulatory Filings Classification · 85% confidence The document is a standalone table of Mainland China investment information filed to Taiwan’s MOPS (‘公開資訊觀測站’) showing quarterly cumulative investments, ownership percentages, and regulatory approval limits. It does not constitute a full interim or annual report with complete financial statements or management analysis—it is a specific regulatory disclosure schedule. It therefore falls under the general “Regulatory Filings” category as a compliance document rather than an interim/quarterly report or other specific filing type.
2026-05-12 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.